In this issue:
Radiotherapy to primary tumour for metastatic prostate cancer
Retzius-sparing robot-assisted radical prostatectomy
Serenoa repens + selenium + lycopene for LUTS
Oncologic outcomes with ORC vs RARC
Stenting after ureterorenoscopic stone extraction
TTNS for overactive bladder
Antimicrobial cost-effectiveness for UTIs
Outcomes of favourable- and low-risk prostate cancer
Sunitinib after nephrectomy in MRCC
Cytoreductive nephrectomy in MRCC
Radical nephrectomy and lymph node dissection for high-risk non-MRCC
Please login below to download this issue (PDF)